Effects of pre-procedural remote ischaemic pre-conditioning on the outcomes of elective percutaneous coronary intervention. A systematic review and meta-analysis
{"title":"Effects of pre-procedural remote ischaemic pre-conditioning on the outcomes of elective percutaneous coronary intervention. A systematic review and meta-analysis","authors":"Nicola King , Gudrun Dieberg , Neil A. Smart","doi":"10.1016/j.ctrsc.2016.06.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Trials of remote ischemic pre-conditioning (RIPC) have suggested this intervention reduces complications of percutaneous coronary intervention and coronary by-pass surgery. The aims of this work were to (i) conduct a systematic review and meta-analysis of the effects of RIPC on cardiac and renal damage in patients undertaking elective percutaneous coronary intervention (PCI); (ii) summarize the results in an evidence-based clinical context.</p></div><div><h3>Methods</h3><p>We conducted a systematic search of published randomized controlled trials of RIPC for elective PCI up until May 1st, 2015. Studies of peri- or post-ischemic conditioning or emergency PCI were excluded.</p></div><div><h3>Results</h3><p>Nine studies, totalling 1253 patients were included. Compared to control, RIPC groups exhibited reduced peri-procedural myocardial infarction (MI) Odds Ratio (OR) 0.72 (95% CI 0.54 to 0.97, <em>p</em> <!-->=<!--> <!-->0.03); ST-segment deviation OR 0.42 (95% CI 0.28 to 0.63, <em>p</em> <!--><<!--> <!-->0.0001); major adverse cardiac events (MACE) OR 0.41 (95% CI 0.21 to 0.84, <em>p</em> <!-->=<!--> <!-->0.01); and acute kidney injury (AKI) OR 0.47 (95% CI 0.26 to 0.86, <em>p</em> <!-->=<!--> <!-->0.01), but not mortality OR 1.00 (95% CI 0.27 to 3.73, <em>p</em> <!-->=<!--> <!-->1.00).</p></div><div><h3>Conclusions</h3><p>RIPC is likely to prevent major adverse cardiac and renal events in patients undertaking elective PCI.</p></div>","PeriodicalId":91232,"journal":{"name":"Clinical trials and regulatory science in cardiology","volume":"21 ","pages":"Pages 1-6"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrsc.2016.06.001","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical trials and regulatory science in cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S240558751630021X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objectives
Trials of remote ischemic pre-conditioning (RIPC) have suggested this intervention reduces complications of percutaneous coronary intervention and coronary by-pass surgery. The aims of this work were to (i) conduct a systematic review and meta-analysis of the effects of RIPC on cardiac and renal damage in patients undertaking elective percutaneous coronary intervention (PCI); (ii) summarize the results in an evidence-based clinical context.
Methods
We conducted a systematic search of published randomized controlled trials of RIPC for elective PCI up until May 1st, 2015. Studies of peri- or post-ischemic conditioning or emergency PCI were excluded.
Results
Nine studies, totalling 1253 patients were included. Compared to control, RIPC groups exhibited reduced peri-procedural myocardial infarction (MI) Odds Ratio (OR) 0.72 (95% CI 0.54 to 0.97, p = 0.03); ST-segment deviation OR 0.42 (95% CI 0.28 to 0.63, p < 0.0001); major adverse cardiac events (MACE) OR 0.41 (95% CI 0.21 to 0.84, p = 0.01); and acute kidney injury (AKI) OR 0.47 (95% CI 0.26 to 0.86, p = 0.01), but not mortality OR 1.00 (95% CI 0.27 to 3.73, p = 1.00).
Conclusions
RIPC is likely to prevent major adverse cardiac and renal events in patients undertaking elective PCI.
目的远程缺血预处理(RIPC)的研究表明,这种干预可以减少经皮冠状动脉介入治疗和冠状动脉旁路手术的并发症。这项工作的目的是:(i)对接受选择性经皮冠状动脉介入治疗(PCI)的患者进行RIPC对心脏和肾脏损害的影响进行系统回顾和荟萃分析;(ii)在循证临床背景下总结结果。方法系统检索截至2015年5月1日已发表的RIPC用于选择性PCI的随机对照试验。排除了缺血前后适应或急诊PCI的研究。结果纳入9项研究,共1253例患者。与对照组相比,RIPC组术中心肌梗死(MI)发生率降低(OR) 0.72 (95% CI 0.54 ~ 0.97, p = 0.03);st段偏差OR 0.42 (95% CI 0.28 ~ 0.63, p <0.0001);主要心脏不良事件(MACE) OR 0.41 (95% CI 0.21 ~ 0.84, p = 0.01);急性肾损伤(AKI) OR为0.47 (95% CI 0.26 ~ 0.86, p = 0.01),但死亡率OR为1.00 (95% CI 0.27 ~ 3.73, p = 1.00)。结论ripc可预防选择性PCI患者发生重大心脏和肾脏不良事件。